• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于胃部给药的基于多孔载体的格列吡嗪漂浮微球的制备及体外表征

Preparation and in vitro Characterization of Porous Carrier-Based Glipizide Floating Microspheres for Gastric Delivery.

作者信息

Pandya N, Pandya M, Bhaskar V H

机构信息

Department of Pharmaceutics, M.P. Patel College of Pharmacy, Jeevanshilp Campus, Kapadwanj, Gujarat - 387 620, India.

出版信息

J Young Pharm. 2011 Apr;3(2):97-104. doi: 10.4103/0975-1483.80292.

DOI:10.4103/0975-1483.80292
PMID:21731353
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3122053/
Abstract

Floating microspheres have been utilized to obtain prolonged and uniform release of drug in the stomach for development of once-daily formulations. A controlled-release system designed to increase residence time in the stomach without contact with the mucosa was achieved through the preparation of floating microspheres by the emulsion solvent diffusion technique, using (i) calcium silicate (CS) as porous carrier; (ii) glipizide, an oral hypoglycemic agent; and (iii) Eudragit(®) S as polymer. The effects of various formulations and process variables on the internal and external particle morphology, micromeritic properties, in vitro floating behavior, drug loading, and in vitro drug release were studied. The microspheres were found to be regular in shape and highly porous. The prepared microspheres exhibited prolonged drug release (~8 h) and remained buoyant for >10 h. The mean particle size increased and the drug release rate decreased at higher polymer concentrations. No significant effect of the stirring rate during preparation on drug release was observed. In vitro studies demonstrated diffusion-controlled drug release from the microspheres. Microsphere formulation CS4, containing 200 mg calcium silicate, showed the best floating ability (88% buoyancy) in simulated gastric fluid. The release pattern of glipizide in simulated gastric fluid from all floating microspheres followed the Higuchi matrix model and the Peppas-Korsmeyer model.

摘要

漂浮微球已被用于实现药物在胃中的长效均匀释放,以开发每日一次的制剂。通过乳液溶剂扩散技术制备漂浮微球,使用(i)硅酸钙(CS)作为多孔载体;(ii)口服降糖药格列吡嗪;以及(iii)Eudragit(®)S作为聚合物,实现了一种无需与粘膜接触即可增加在胃中停留时间的控释系统。研究了各种制剂和工艺变量对颗粒内外形态、粉体学性质、体外漂浮行为、载药量和体外药物释放的影响。发现微球形状规则且孔隙率高。制备的微球显示出长效药物释放(约8小时),并在超过10小时内保持漂浮。在较高聚合物浓度下,平均粒径增大,药物释放速率降低。未观察到制备过程中的搅拌速率对药物释放有显著影响。体外研究表明药物从微球中以扩散控制方式释放。含有200mg硅酸钙的微球制剂CS4在模拟胃液中显示出最佳的漂浮能力(88%浮力)。所有漂浮微球中格列吡嗪在模拟胃液中的释放模式均符合Higuchi基质模型和Peppas-Korsmeyer模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd02/3122053/f51d5c9fb0cb/JYPharm-3-97-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd02/3122053/14b2bf0fd504/JYPharm-3-97-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd02/3122053/7d9899e234eb/JYPharm-3-97-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd02/3122053/f51d5c9fb0cb/JYPharm-3-97-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd02/3122053/14b2bf0fd504/JYPharm-3-97-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd02/3122053/7d9899e234eb/JYPharm-3-97-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd02/3122053/f51d5c9fb0cb/JYPharm-3-97-g004.jpg

相似文献

1
Preparation and in vitro Characterization of Porous Carrier-Based Glipizide Floating Microspheres for Gastric Delivery.用于胃部给药的基于多孔载体的格列吡嗪漂浮微球的制备及体外表征
J Young Pharm. 2011 Apr;3(2):97-104. doi: 10.4103/0975-1483.80292.
2
Evaluation of porous carrier-based floating orlistat microspheres for gastric delivery.基于多孔载体的漂浮型奥利司他微球用于胃内给药的评价。
AAPS PharmSciTech. 2006 Nov 10;7(4):90. doi: 10.1208/pt070490.
3
Calcium silicate based microspheres of repaglinide for gastroretentive floating drug delivery: preparation and in vitro characterization.用于胃滞留漂浮给药的瑞格列奈硅酸钙基微球:制备与体外表征
J Control Release. 2005 Oct 3;107(2):300-9. doi: 10.1016/j.jconrel.2005.06.007.
4
Chitosan-based Floating Microspheres of Trimetazidin Dihydrochloride; Preparation and In vitro Characterization.基于壳聚糖的盐酸曲美他嗪漂浮微球;制备及体外表征
Indian J Pharm Sci. 2011 Jul;73(4):397-403. doi: 10.4103/0250-474X.95619.
5
In vitro Evaluation of Novel Sustained Release Microspheres of Glipizide Prepared by the Emulsion Solvent Diffusion-Evaporation Method.采用乳液溶剂扩散-蒸发法制备的新型格列吡嗪缓释微球的体外评价
J Young Pharm. 2010 Jan;2(1):35-41. doi: 10.4103/0975-1483.62210.
6
Floating controlled drug delivery system of famotidine loaded hollow microspheres (microballoons) in the stomach.载盐酸法莫替丁空心微球(微球)的漂浮控释给药系统在胃部。
Curr Drug Deliv. 2010 Jan;7(1):93-7. doi: 10.2174/156720110790396436.
7
Floating microspheres of cimetidine: formulation, characterization and in vitro evaluation.西咪替丁漂浮微球:制剂、表征及体外评价
Acta Pharm. 2005 Sep;55(3):277-85.
8
Floating microspheres of carvedilol as gastro retentive drug delivery system: 3(2) full factorial design and in vitro evaluation.卡维地洛漂浮微球作为胃滞留型药物传递系统:3(2)完全因子设计及体外评价。
Drug Deliv. 2014 Mar;21(2):110-7. doi: 10.3109/10717544.2013.834414. Epub 2013 Sep 12.
9
Biodegradable anionic acrylic resin based hollow microspheres of moderately water soluble drug rosiglitazone maleate: preparation and in vitro characterization.基于可生物降解阴离子型丙烯酸树脂的马来酸罗格列酮中空微球的制备及体外特性研究。
Drug Dev Ind Pharm. 2012 Dec;38(12):1460-9. doi: 10.3109/03639045.2011.653811. Epub 2012 Feb 23.
10
Cellulose acetate microspheres as floating depot systems to increase gastric retention of antidiabetic drug: formulation, characterization and in vitro-in vivo evaluation.醋酸纤维素微球作为增加抗糖尿病药物胃滞留的漂浮长效释放系统:制剂、表征及体内外评价
Drug Dev Ind Pharm. 2008 Apr;34(4):349-54. doi: 10.1080/03639040701542531.

引用本文的文献

1
Evaluation of Ulcer Protective Activity of L. Extract-Loaded Chitosan Microspheres in Ethanol-Induced Ulcer in Rat Model.载L.提取物的壳聚糖微球对大鼠乙醇诱导溃疡的溃疡保护活性评价
Evid Based Complement Alternat Med. 2022 Sep 30;2022:4907585. doi: 10.1155/2022/4907585. eCollection 2022.
2
Floating Microspheres of Enalapril Maleate as a Developed Controlled Release Dosage Form: Investigation of the Effect of an Ionotropic Gelation Technique.马来酸依那普利漂浮微球作为一种新型控释剂型:离子凝胶技术效果的研究
Turk J Pharm Sci. 2020 Apr;17(2):159-171. doi: 10.4274/tjps.galenos.2018.15046. Epub 2020 Apr 24.
3

本文引用的文献

1
Evaluation of porous carrier-based floating orlistat microspheres for gastric delivery.基于多孔载体的漂浮型奥利司他微球用于胃内给药的评价。
AAPS PharmSciTech. 2006 Nov 10;7(4):90. doi: 10.1208/pt070490.
2
Formulation and evaluation of mucoadhesive glipizide microspheres.黏附性格列吡嗪微球的制剂与评价
AAPS PharmSciTech. 2005 Sep 20;6(1):E49-55. doi: 10.1208/pt060110.
3
In vitro evaluation of floating and drug releasing behaviors of hollow microspheres (microballoons) prepared by the emulsion solvent diffusion method.
Improved Stability of Rifampicin in the Presence of Gastric-Resistant Isoniazid Microspheres in Acidic Media.
在酸性介质中,耐胃酸异烟肼微球存在下利福平稳定性的提高
Pharmaceutics. 2020 Mar 5;12(3):234. doi: 10.3390/pharmaceutics12030234.
4
Development of floating chitosan-xanthan beads for oral controlled release of glipizide.用于格列吡嗪口服控释的壳聚糖-黄原胶漂浮珠的研制。
Int J Pharm Investig. 2015 Apr-Jun;5(2):73-80. doi: 10.4103/2230-973X.153381.
乳液溶剂扩散法制备的中空微球(微球囊)的漂浮及释药行为的体外评价
Eur J Pharm Biopharm. 2004 Mar;57(2):235-43. doi: 10.1016/S0939-6411(03)00185-1.
4
Physicochemical properties to determine the buoyancy of hollow microspheres (microballoons) prepared by the emulsion solvent diffusion method.通过乳液溶剂扩散法制备的中空微球(微球囊)浮力测定的物理化学性质。
Eur J Pharm Biopharm. 2003 May;55(3):297-304. doi: 10.1016/s0939-6411(03)00003-1.
5
In vitro and in vivo evaluation of potassium chloride sustained release formulation prepared with saturated polyglycolyed glycerides matrices.用饱和聚乙二醇化甘油酯基质制备的氯化钾缓释制剂的体外和体内评价
Int J Pharm. 2002 Aug 28;243(1-2):119-24. doi: 10.1016/s0378-5173(02)00264-8.
6
Use of floating alginate gel beads for stomach-specific drug delivery.使用漂浮藻酸盐凝胶珠进行胃特异性药物递送。
Eur J Pharm Biopharm. 2000 Sep;50(2):221-6. doi: 10.1016/s0939-6411(00)00110-7.
7
PVP solid dispersions for the controlled release of furosemide from a floating multiple-unit system.用于从漂浮多单元系统中控制释放呋塞米的聚乙烯吡咯烷酮固体分散体。
Drug Dev Ind Pharm. 2000 Jun;26(6):595-603. doi: 10.1081/ddc-100101274.
8
Effect of formulation and processing variables on the characteristics of microspheres for water-soluble drugs prepared by w/o/o double emulsion solvent diffusion method.制剂和工艺变量对采用水包油包水双乳液溶剂扩散法制备的水溶性药物微球特性的影响。
Int J Pharm. 2000 Feb 25;196(1):75-83. doi: 10.1016/s0378-5173(99)00440-8.
9
Floating dosage forms: an in vivo study demonstrating prolonged gastric retention.漂浮剂型:一项证明胃内滞留时间延长的体内研究。
J Control Release. 1998 Oct 30;55(1):3-12. doi: 10.1016/s0168-3659(97)00266-6.
10
Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets.比较酒石酸美托洛尔片溶出曲线的方法及制定宽溶出度标准的理论依据。
J Pharm Sci. 1997 Jun;86(6):690-700. doi: 10.1021/js960473x.